Large hepatitis delta antigen activates STAT‐3 and NF‐κB via oxidative stress
Virginie Williams(Inserm), Emmanuel Gordien(Université Paris Cité), Ségolène Brichler(Centre National de la Recherche Scientifique), Mounia Chami(Centre National de la Recherche Scientifique), Elaine M. Khan(California Environmental Protection Agency), Paul Dény(Université Sorbonne Paris Nord), Dina Kremsdorf(Inserm)
Cited by 62
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease
|Journal of Neuroscience|2012|234
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206